The Food and Drug Administration (FDA) inspected Anodyne Therapy, LLC in Oldsmar on April 22, according to information from the FDA’s website.
Inspection areas included:
- Compliance: Devices
- Postmarket Assurance: Devices
The final report noted that Anodyne Therapy, LLC was not required to make any changes to its management operations.
The FDA regularly inspects facilities across the United States to determine compliance with FDA regulations, which aim to safeguard public health. Outcomes of these inspections are made available to the public.
As stated on its website, the FDA is a federal agency that oversees the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data is available here.
